Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Health Technology Assessment (Winchester, England)|October 1, 2020
Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluationMatthew Walton, Ros Wade, Lindsay Claxton, et al.Diabetes Care|October 29, 2002
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetesMartin St John Sutton, Marc Rendell, Paresh Dandona, et al.Molecular Psychiatry|August 23, 2025
Histone demethylase PHF2 regulates inflammatory genes in Alzheimer's diseaseGuojun Yang, Yong Ren, Ping Zhong, et al.Gut|May 30, 2020
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of PathologyJames Neuberger, Jai Patel, Helen Caldwell, et al.Journal of Vascular and Interventional Radiology : JVIR|October 31, 2009
Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registryStuart M Lyon, Guillermo Elizondo Riojas, Raman Uberoi, et al.Anti-Cancer Drugs|January 19, 2013
Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumorsDon W Coulter, Christine Walko, Jai Patel, et al.Pharmacogenomics|October 17, 2023
Evaluation of pentamidine tolerability and efficacy between <i>CYP2C19</i> phenotypesAlexis Koon, Jiaxian He, Jai Patel, et al.Clinical Genitourinary Cancer|May 2, 2024
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With ChemotherapyLandon C Brown, Myra Robinson, Michael McCormack, et al.The Oncologist|June 5, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancerHanna K Sanoff, Allison M Deal, Jai Patel, et al.Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.Pageof 4